HyperMed’s latest news

HyperMed Imaging, Inc. Relocates Offices to Memphis, TN

February 1, 2015 / Memphis, TN

HyperMed Imaging, Inc. has relocated its headquarters from Greenwich, CT to Memphis, TN. The company made the decision based on a number of factors including improved cost of operations and availability of highly qualified medical device industry talent in the Memphis area. HyperMed’s CEO Mark Darty commented that, “The Memphis area is one of several nexus locations in the US for medical device companies and related technology. By relocating to Memphis, we positioned the company for growth as we seek to develop and launch our next generation of medical imaging devices.”

HyperMed Imaging continues to make progress toward the development of its new medical device for tissue oximetry and has recently completed preproduction prototype devices that will be utilized for development testing, clinical studies and certification activities. The company is expanding and actively hiring for a range of qualifications including product development, operations management, clinical research, regulatory compliance, and quality management systems.

HyperMed Imaging, Inc. is a privately owned medical device company and the market leader in hyperspectral medical imaging. HyperMed pioneered the use of its novel version of hyperspectral imaging for assessment of surface tissue oximetry with its OxyVu™-1 device, first cleared by the FDA in 2006. HyperMed’s OxyVu-1 has been successfully used across America for many years, generating substantial clinical research into the use of the technology for a number of applications involving circulatory compromise. HyperMed is not currently selling any medical device and is focusing its efforts toward a new generation of devices using its hyperspectral imaging technology.

HyperMed’s new tissue oximetry device called HyperView™ is FDA 510(k) cleared.
HyperMed, HyperView, OxyVu™-1 and the company logo are trademarks of HyperMed Imaging, Inc.